These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22574616)

  • 1. Cost effectiveness of drug-eluting stents in acute myocardial infarction patients in Germany: results from administrative data using a propensity score-matching approach.
    Bäumler M; Stargardt T; Schreyögg J; Busse R
    Appl Health Econ Health Policy; 2012 Jul; 10(4):235-48. PubMed ID: 22574616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.
    Goeree R; Bowen JM; Blackhouse G; Lazzam C; Cohen E; Chiu M; Hopkins R; Tarride JE; Tu JV
    Int J Technol Assess Health Care; 2009 Apr; 25(2):196-207. PubMed ID: 19331710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
    Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
    EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
    Schafer PE; Sacrinty MT; Cohen DJ; Kutcher MA; Gandhi SK; Santos RM; Little WC; Applegate RJ
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):408-15. PubMed ID: 21693724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea.
    Kim KH; Koo BK; Min HS; Park SK; Kim CH; Park KW; Park BJ; Jeong MH; Cho MC; Lee SR; Chae SC; Seong IW; Choi DJ; Kim HS
    Int J Cardiol; 2012 Jan; 154(1):71-7. PubMed ID: 20888053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ; Sattur S; Orshaw P; Boura J
    J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of drug-eluting coronary stents among Medicare beneficiaries.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    Am Heart J; 2008 Jun; 155(6):1097-105. PubMed ID: 18513525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry.
    Ong AT; Daemen J; van Hout BA; Lemos PA; Bosch JL; van Domburg RT; Serruys PW
    Eur Heart J; 2006 Dec; 27(24):2996-3003. PubMed ID: 17114234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.
    Li Y; Han YL; Zhang QY; Guan SY; Wang XZ; Jing QM; Ma YY; Wang G; Wang B; Deng J
    Chin Med J (Engl); 2011 Mar; 124(6):825-30. PubMed ID: 21518587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
    Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
    Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial.
    Canoui-Poitrine F; Jeanblanc G; Alberti C; Armoogum P; Cebrian A; Carrié D; Henry P; Teiger E; Slama M; Spaulding C; Durand-Zaleski I
    Appl Health Econ Health Policy; 2009; 7(1):19-29. PubMed ID: 19558192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.
    Kukreja N; Onuma Y; Garcia-Garcia H; Daemen J; van Domburg R; Serruys PW
    Circ Cardiovasc Interv; 2008 Oct; 1(2):103-10. PubMed ID: 20031664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
    Pasceri V; Patti G; Speciale G; Pristipino C; Richichi G; Di Sciascio G
    Am Heart J; 2007 May; 153(5):749-54. PubMed ID: 17452148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.